On September 23, 2013, LabStyle Innovations Corp. (NASDAQ:DRIO) announced the receipt of CE Mark approval to market the Dario smartphone-based diabetes management system in 32 countries across Europe as well as in certain other countries worldwide. The initial roll-out of the Dario device will take place in countries where management has signed distribution partners. This includes launching the device in The U.K., and Belgium under the company's exclusive distribution agreement with Farla Medical, Inc. in Italy under an exclusive distribution agreement with Harmonium Pharma, and in New Zealand with recent distribution partner, InnoMed Ltd.
Management expects these launches to take place, along with a soft roll-out in New Zealand and Australia, in the first quarter 2014. Between...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|